Munteanu Ioana, Gheorghevici Constantin, Coca Catalin Constantin, Diaconu George Alexandru, Sandru Alexandra Emilia, Feraru Nicolae, Popa Andreea, Nemes Roxana, Mahler Beatrice
Faculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.
"Marius Nasta" Institute of Pneumophtisyiology, 050159 Bucharest, Romania.
Life (Basel). 2023 Oct 20;13(10):2089. doi: 10.3390/life13102089.
Bronchopulmonary cancer is the leading cause of cancer deaths globally. Rheumatoid arthritis is one of the risk factors for lung cancer, and those who use methotrexate have a higher risk of developing lung cancer. We present the case of an 80-year-old patient who is a former smoker and is known to have rheumatoid arthritis, being treated using methotrexate; they were brought by ambulance to the emergency room for coughing with ineffective expectoration, dyspnea on slight exertion, and right-lateral chest pain with onset about one month prior and progressive worsening. Imaging showed a 7 cm/6 cm LID tumorous lung formation with parietal invasion and C7 rib lysis, as well as diffuse fibrotic interstitial changes predominantly in the lower lobes. An ultrasound-guided transthoracic lung biopsy was performed, and histopathological examination established the diagnosis of invasive squamous cell lung carcinoma, G2. In conclusion, the chest pain interpreted by the patient as rheumatic pain delayed the diagnosis of lung cancer; the patient presented rather late to the hospital once respiratory failure set in.
支气管肺癌是全球癌症死亡的主要原因。类风湿性关节炎是肺癌的危险因素之一,使用甲氨蝶呤的人患肺癌的风险更高。我们报告一例80岁患者,该患者曾吸烟,已知患有类风湿性关节炎,正在接受甲氨蝶呤治疗;患者因咳嗽咳痰无效、轻微活动后呼吸困难以及右侧胸痛被救护车送往急诊室,胸痛约1个月前开始,且进行性加重。影像学检查显示一个7厘米/6厘米的肺叶内肿瘤性病变,伴有胸膜侵犯和C7肋骨溶解,以及主要在下叶的弥漫性纤维化间质改变。进行了超声引导下经胸肺活检,组织病理学检查确诊为浸润性肺鳞状细胞癌,G2级。总之,患者将胸痛解释为风湿性疼痛,这延误了肺癌的诊断;一旦出现呼吸衰竭,患者就医时病情已相当严重。